BOVILIS VL5 SQ

Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

BOVILIS VL5 SQ Indications

This product has been shown effective for the vaccination of healthy cattle against Leptospira canicola, L. grippotyphosa, L. hardjo -including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona and reproductive disease caused by Campylobacter fetus. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product has been shown to be effective against urinary shedding of L. hardjo organisms.

MIXING & USE DIRECTIONS: Shake well and administer a single 2.0 mL dose aseptically by subcutaneous route 14-60 days prior to breeding. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For more information on revaccination frequency consult your veterinarian. If packaged with Vista^® 5 SQ refer to carton for complete directions.

CAUTIONS: Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products except as specified on the label. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. If allergic reaction occurs, treat with epinephrine. In case of human exposure, contact a physician. Contains thimerosal as a preservative.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/see carton for PCN

1-800-521-5767

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047564.0